We are exceptionally proud to welcome to our team, starting January, our new Head of Quality Assurance, Dr. Miroslav Janousek.

With vast experience in the pharmaceutical industry, he will undoubtedly become a key part of the Quinta team and aid us in our continued growth.

Starting in the industry 30 years ago at the Charles University in Hradec Králové, CZ, he dedicated his career-to-date at Zentiva where he served as a member of the corporate senior management team.

Holding positions of responsibility across Quality, Regulatory, and Pharmacovigilance, he played a key part in the building of a highly renowned quality system and contributed to the Regulatory Affairs function in different stages of Zentiva’s development. Enabling it to grow from a regional player to the global Gx business of Sanofi.

Deeply involved in projects in Europe, Latin America, Southeast Asia & the Middle East throughout his career, he joins QUINTA-ANALYTICA ready to contribute to enhancing our team and ensuring we remain a leading provider of high quality analytical and clinical services for pharmadevelopment and manufacturing.

His experience will further strengthen Quinta and will help power the top-class services we provide globally.

Welcome on-board, Miroslav.

Additional News

  • 22 června 2023

    Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

    EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

  • 15 června 2023

    Novavax & Conscio: Behind the Scenes of Vaccine Development

    Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.

  • 8 června 2023

    Clinical Tips – Drug Interactions in Advanced Clinical Trial Design

    Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.